XRAY - DENTSPLY SIRONA Inc.
Dopo ore:
| Chiusura precedente | 38,71 |
| Aperto | 38,73 |
| Denaro | 38,44 x 1200 |
| Lettera | 39,18 x 800 |
| Min-Max giorno | 38,29 - 38,80 |
| Intervallo di 52 settimane | 26,48 - 43,24 |
| Volume | |
| Media Volume | 1.859.957 |
| Capitalizzazione | 8,163B |
| Beta (5 anni mensile) | 0,92 |
| Rapporto PE (ttm) | N/D |
| EPS (ttm) | -4,84 |
| Prossima data utili | 02 ago 2023 - 07 ago 2023 |
| Rendimento e dividendo (forward) | 0,56 (1,43%) |
| Data ex dividendo | 29 giu 2023 |
| Stima target 1A | 44,70 |
GlobeNewswireDentsply Sirona Declares Quarterly Cash Dividend
CHARLOTTE, N.C., May 24, 2023 (GLOBE NEWSWIRE) -- DENTSPLY SIRONA Inc. (“Dentsply Sirona”) (Nasdaq: XRAY), announced that its Board of Directors declared a quarterly cash dividend of $0.14 per share of common stock, an indicated annual rate of $0.56 per share. The dividend is payable on July 14, 2023, to holders of record as of June 30, 2023. About Dentsply Sirona Dentsply Sirona is the world’s largest manufacturer of professional dental products and technologies, with over a century of innovati
- GlobeNewswire
Dentsply Sirona to Participate in Upcoming Investor Conferences
CHARLOTTE, N.C., May 08, 2023 (GLOBE NEWSWIRE) -- DENTSPLY SIRONA Inc. (“Dentsply Sirona”) (Nasdaq: XRAY) today announced its participation at upcoming conferences. Bank of America Securities 2023 Healthcare Conference on May 10, 2023, at 8:00 am PT (11:00 am ET)Stifel 2023 Jaws & Paws Conference on June 1, 2023, at 8:00 am ETGoldman Sachs 44th Annual Global Healthcare Conference on June 14, 2023, at 8:40 am PT (11:40 am ET) Investors and other interested parties will be able to access a live we
- GlobeNewswire
Dentsply Sirona Reports First Quarter 2023 Results
Net sales increased 0.9% to $978 million, organic sales increased 5.1%GAAP net loss of ($19) million, GAAP loss per share of ($0.09)Adjusted EBITDA of $161 million, adjusted EPS of $0.39Raising low-end of FY23 net sales outlook by $50 million and low-end of organic sales growth outlook by 100 basis pointsRaising low-end of FY23 adjusted EPS outlook by $0.05 CHARLOTTE, N.C., May 03, 2023 (GLOBE NEWSWIRE) -- DENTSPLY SIRONA Inc. (“Dentsply Sirona” or the “Company”) (Nasdaq: XRAY) today announced i
- GlobeNewswire
Dentsply Sirona to Host First Quarter Conference Call on May 3rd
CHARLOTTE, N.C., April 05, 2023 (GLOBE NEWSWIRE) -- DENTSPLY SIRONA Inc. (“Dentsply Sirona”) (Nasdaq: XRAY) today announced that the Company will be hosting an investor conference call and live webcast on Wednesday, May 3, 2023, at 8:30 am ET to review its first quarter financial results. A presentation related to the call will be available on the Investors section of the Company’s website at https://investor.dentsplysirona.com. Conference Call / Webcast Information A live webcast will be availa
- GlobeNewswire
Dentsply Sirona Announces $150 Million Accelerated Share Repurchase Program
CHARLOTTE, N.C., March 06, 2023 (GLOBE NEWSWIRE) -- DENTSPLY SIRONA Inc. (“Dentsply Sirona” or the “Company”) (Nasdaq: XRAY) today announced that it has entered into an accelerated share repurchase agreement (the “ASR”) with Goldman Sachs & Co. LLC to repurchase $150 million of its common stock. The ASR agreement will be completed under Dentsply Sirona’s current share repurchase authorization. Under the terms of the ASR, Dentsply Sirona will initially receive delivery of approximately 3.1 millio
- GlobeNewswire
Dentsply Sirona Reports Fourth Quarter and Full Year 2022 Results, Provides Full Year 2023 Outlook
FY22 net sales decreased (7.3%) to $3,922 million, organic sales decreased (0.5%)FY22 GAAP EPS of ($4.41), adjusted EPS of $2.09Q4 net sales decreased (10.9%) to $983 million, organic sales decreased (2.6%)Q4 GAAP EPS of ($0.07), adjusted EPS of $0.46FY23 outlook: net sales of $3.85 - $3.95 billion, organic sales down (1%) to up 2%, adj. EPS range of $1.80 to $2.00 CHARLOTTE, N.C., Feb. 28, 2023 (GLOBE NEWSWIRE) -- DENTSPLY SIRONA Inc. (“Dentsply Sirona” or the "Company") (Nasdaq: XRAY) today an
- GlobeNewswire
Dentsply Sirona Announces Organizational Changes to Simplify Structure, Enhance Profitability, Improve Operational Performance and Drive Growth
Expects to Achieve $200 to $225 million in Annual Cost Savings Portfolio Evaluation and Simplification Plan Ongoing CHARLOTTE, N.C., Feb. 16, 2023 (GLOBE NEWSWIRE) -- DENTSPLY SIRONA Inc. (“Dentsply Sirona” or the “Company”) (Nasdaq: XRAY) today announced that its Board of Directors approved an organizational restructuring plan intended to improve operational performance and drive shareholder value creation. The plan is anticipated to achieve at least $200 million in annual cost savings over the
- GlobeNewswire
Dentsply Sirona to Host Fourth Quarter and Full Year 2022 Conference Call on February 28th
CHARLOTTE, N.C., Feb. 02, 2023 (GLOBE NEWSWIRE) -- DENTSPLY SIRONA Inc. (“Dentsply Sirona”) (Nasdaq: XRAY) today announced that the Company will be hosting an investor conference call and live webcast on Tuesday, February 28, 2023, at 8:30 am ET to review its fourth quarter and full year 2022 financial results. A presentation related to the call will be available on the Investors section of the Company’s website at https://investor.dentsplysirona.com. Conference Call / Webcast Information A live
- GlobeNewswire
Dentsply Sirona to Present at J.P. Morgan Healthcare Conference, Provides Update on Anticipated Full Year 2022 Results
CHARLOTTE, N.C., Jan. 11, 2023 (GLOBE NEWSWIRE) -- DENTSPLY SIRONA Inc. (“Dentsply Sirona” or the “Company”) (Nasdaq: XRAY) will present at the 41st Annual J.P. Morgan Healthcare Conference on Wednesday, January 11, 2023, at 10:30 am PT (1:30 pm ET). As part of the conference, the Company is providing an update on its anticipated financial results with net sales expected to be above the high end of the Company’s prior outlook range of $3.85 billion to $3.88 billion. Full year 2022 adjusted EPS i
- GlobeNewswire
Dentsply Sirona to Present at the 41st Annual J.P. Morgan Healthcare Conference
CHARLOTTE, N.C., Dec. 20, 2022 (GLOBE NEWSWIRE) -- DENTSPLY SIRONA Inc. (“Dentsply Sirona”) (Nasdaq: XRAY) today announced that the company will participate in the 41st Annual J.P. Morgan Healthcare Conference. Management is scheduled to present on Wednesday, January 11, 2023, at 10:30 am PT (1:30 pm ET). Investors and other interested parties will be able to access a live audio webcast of the presentation and audio webcast replay by visiting the Investors section of the Dentsply Sirona website
- GlobeNewswire
Dentsply Sirona Reports Third Quarter 2022 Results
Net sales decreased (8.9%) to $947 million, organic sales decreased (0.7%)GAAP EPS loss of ($5.01), adjusted EPS of $0.41 down (31.5%) year-over-yearOperating cash flow of $109 millionUpdated FY22 outlook: organic sales decline of ~(2%); adj. EPS range of $1.90 to $2.00 CHARLOTTE, N.C., Nov. 14, 2022 (GLOBE NEWSWIRE) -- DENTSPLY SIRONA Inc. (“Dentsply Sirona” or the "Company") (Nasdaq: XRAY) today announced its financial results for the third quarter of 2022. Third quarter net sales of $947 mill
- GlobeNewswire
Dentsply Sirona to Host Third Quarter Conference Call on November 14th
CHARLOTTE, N.C., Nov. 09, 2022 (GLOBE NEWSWIRE) -- DENTSPLY SIRONA Inc. (“Dentsply Sirona”) (Nasdaq: XRAY) today announced that the Company will be hosting an investor conference call and live webcast on Monday, November 14, 2022, at 8:30 am ET to review its third quarter financial results. A presentation related to the call will be available on the Investors section of the Company’s website at https://investor.dentsplysirona.com. Conference Call / Webcast Information A live webcast will be avai
- GlobeNewswire
Dentsply Sirona Completes Internal Investigation
Announces Restatements of Third Quarter 2021 and Full Year 2021 Financials Reports Select Preliminary Third Quarter 2022 Results CHARLOTTE, N.C., Nov. 01, 2022 (GLOBE NEWSWIRE) -- DENTSPLY SIRONA Inc. (“Dentsply Sirona” or “the Company”) (Nasdaq: XRAY) today announced the completion of the previously disclosed internal investigation into certain financial reporting matters. The investigation was undertaken by the Audit and Finance Committee of the Dentsply Sirona Board of Directors (the “Audit a
- GlobeNewswire
Dentsply Sirona Appoints Glenn Coleman as Chief Financial Officer
CHARLOTTE, N.C., Sept. 22, 2022 (GLOBE NEWSWIRE) -- DENTSPLY SIRONA Inc. (“Dentsply Sirona” or the “Company”) (Nasdaq: XRAY) today announced that Glenn Coleman has been appointed Executive Vice President and Chief Financial Officer, effective September 26, 2022. He succeeds Barbara Bodem, who has served as Interim Chief Financial Officer since May 2022. Ms. Bodem will remain with the company and continue to serve as an advisor to Mr. Coleman until October 24, 2022. Mr. Coleman brings 30 years of
- GlobeNewswire
Dentsply Sirona Appoints Simon Campion as Chief Executive Officer
CHARLOTTE, N.C., Aug. 25, 2022 (GLOBE NEWSWIRE) -- Dentsply Sirona Inc. (“Dentsply Sirona” or the “Company”) (Nasdaq: XRAY) today announced that Simon Campion has been appointed President and Chief Executive Officer and will join the Company’s Board of Directors (“Board”), effective September 12, 2022. He succeeds John Groetelaars, who has served as Interim Chief Executive Officer since April 2022. Mr. Groetelaars will continue to serve on the Board. Mr. Campion joins Dentsply Sirona from Becton
- GlobeNewswire
Dentsply Sirona Receives Notice of Filing Delinquency from Nasdaq
CHARLOTTE, N.C., Aug. 15, 2022 (GLOBE NEWSWIRE) -- DENTSPLY SIRONA Inc. (“Dentsply Sirona” or the "Company") (Nasdaq: XRAY) today announced that, as expected, it received written notification from The NASDAQ Stock Market (“Nasdaq”) on August 12, 2022 that the Company remains out of compliance with the Nasdaq Listing Rules because the Company has not yet filed its Quarterly Reports on Form 10-Q for the periods ended March 31, 2022 and June 30, 2022 (individually the “First Quarter 10-Q” and “Seco
- GlobeNewswire
Dentsply Sirona Provides Business Update
Company Provides Select Preliminary Second Quarter 2022 Results Company Provides Update on Previously Announced Investigation Company Provides Nasdaq Compliance Update CHARLOTTE, N.C., Aug. 04, 2022 (GLOBE NEWSWIRE) -- DENTSPLY SIRONA Inc. (“Dentsply Sirona” or “the Company”) (Nasdaq: XRAY) today is providing a business update. As previously disclosed, the Audit and Finance Committee of the Company’s Board of Directors (the “Audit Committee”) is conducting an internal investigation regarding cer